PerlJ., BargmanJ.M.The importance of residual kidney function for patients on dialysis: a critical review.Am J Kidney Dis2009; 53: 1068–81.
2.
ZhongY., DengY., ChenY., ChuangP.Y., Cijiang HeJ.Therapeutic use of traditional Chinese herbal medications for chronic kidney diseases.Kidney Int2013; 84: 1108–18.
3.
RenS., ZhangH., MuY., SunM., LiuP.Pharmacological effects of Astragaloside IV: a literature review.J Tradit Chin Med2013; 33: 413–6.
4.
BlakeP.G., JainA.K., YohannaS.Biocompatible peritoneal dialysis solutions: many questions but few answers.Kidney Int2013; 84: 864–6.
5.
McCaffertyK., FanS., DavenportA.Extracellular volume expansion, measured by multifrequency bioimpedance, does not help preserve residual renal function in peritoneal dialysis patients.Kidney Int2014; 85: 151–7.
6.
ZhangJ., XieX., LiC., FuP.Systemic review of the renal protective effect of Astragalus membranaceus (root) on diabetic nephropathy in animal models.J Ethnopharmacol2009; 126: 189–96.
7.
WangH., LiJ., YuL., ZhaoY., DingW.Antifibrotic effect of the Chinese herbs, Astragalus mongholicus and Angelica sinensis, in a rat model of chronic puromycin aminonucleoside nephrosis.Life Sci2004; 74: 1645–58.
8.
ZhangY.W., XieD., XiaB., ZhenR.T., LiuI.M., ChengJ.T.Suppression of transforming growth-factor-beta 1 gene expression by Danggui buxue tang, a traditional Chinese herbal preparation, in retarding the progress of renal damage in streptozotocin-induced diabetic rats.Horm Metab Res2006; 38: 82–8.
9.
MengL., QuL., TangJ., CaiS.Q., WangH., LiX.A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, enhanced nitric oxide production in obstructed rat kidney.Vascul Pharmacol2007; 47: 174–83.
10.
XuB.Chinese herbal medicine and formulations. In: YanC.S., BieberE.J., BauerB.A., eds. Traditional Chinese Medicine.London: Informa healthcare; 2011: 113–24.
